Search

Your search keyword '"Halabi H"' showing total 187 results
Start Over Author "Halabi H"
187 results on '"Halabi H"'

1. Spontaneous Pneumomediastinum and Subcutaneous Emphysema in Dermatomyositis: A Case Series and Literature Review

Author

Subki AH, Almani IM, Albeity A, Aljabri BK, Alsolaimani R, and Halabi H

Subjects
dermatomyositis, pneumomediastinum, subcutaneous emphysema, pneumothorax, corticosteroids, immunosuppressants, rituximab, Pathology, RB1-214, Therapeutics. Pharmacology, RM1-950
Abstract

Ahmed Hussein Subki,1 Ibraheem Mohammed Almani,2 Abdurahman Albeity,1 Bandari Khalid Aljabri,1 Roaa Alsolaimani,1,2 Hussein Halabi1 1Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia; 2Department of Medicine, King Abdulaziz University Hospital, Jeddah, Saudi ArabiaCorrespondence: Ahmed Hussein Subki; Hussein Halabi, Department of Internal Medicine, King Faisal Specialist Hospital & research center, POBox: 43129, Jeddah, 21561, Saudi Arabia, Tel +966566724288, Email subki.research@gmail.com; mfasel@gmail.comBackground: Spontaneous pneumomediastinum and subcutaneous emphysema are rare and serious complications of dermatomyositis (DM).Case Presentation: Our article presents two clinically heterogeneous cases of DM who developed pneumomediastinum and subcutaneous emphysema. The first was a 24-year-old lady with a recently diagnosed DM. She developed rapidly progressive pneumonia, interstitial lung disease (ILD), pneumomediastinum, subcutaneous emphysema, and acute respiratory distress syndrome (ARDS). She died despite treatment with steroids and immunosuppressants (methotrexate and mycophenolate mofetil (MMF)). The second was a 30-year-old man diagnosed with amyopathic DM. He developed pneumomediastinum prior to ILD, which worsened over time, and subcutaneous emphysema evolved. However, he recovered completely after corticosteroid, MMF, and rituximab.Conclusion: Spontaneous pneumomediastinum and subcutaneous emphysema may complicate DM. Corticosteroids, immunosuppressants, and respiratory support are the mainstay of management for these conditions. Though they were reported to carry a poor prognostic value, the course and outcome are highly variable among the cases.Keywords: dermatomyositis, pneumomediastinum, subcutaneous emphysema, pneumothorax, corticosteroids, immunosuppressants, rituximab

Published
2023

2. Dermatomyositis Flare After a COVID-19 Infection Successfully Treated with Rituximab: A Case Report and Literature Review

Author

Albakri AM, Subki AH, Albeity A, and Halabi H

Subjects
covid-19 infection, dermatomyositis., Pathology, RB1-214, Therapeutics. Pharmacology, RM1-950
Abstract

Ahmed Mohammed Albakri, Ahmed Hussein Subki, Abdurahman Albeity, Hussein Halabi Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi ArabiaCorrespondence: Ahmed Hussein Subki; Hussein Halabi, Department of Internal Medicine, King Faisal Specialist Hospital and Research Center, POBox: 43129, Jeddah, 21561, Saudi Arabia, Tel +966566724288, Email subki.research@gmail.com; mfasel@gmail.comIntroduction: Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been a sudden surge in the incidence of several immune-mediated diseases, including dermatomyositis. The reported cases of COVID-19-related dermatomyositis are heterogeneous in their clinical presentation and implemented therapies.Case Study: We report a 23-year-old female patient diagnosed with a 3-year history of dermatomyositis. She has been well-controlled on maintenance therapy. However, 6 weeks after a mild COVID-19 infection, she developed a dermatomyositis flare. She improved only after aggressive treatment with pulse steroids, intravenous immunoglobulin, and rituximab.Conclusion: Exacerbation of dermatomyositis can be encountered following a COVID-19 infection, even if the infection is mild. Aggressive therapy should be considered in such cases. The prognosis, however, is generally favorable.Keywords: COVID-19 infection, dermatomyositis, Rituximab

Published
2022

3. Future Directions of Rheumatology Training According to Saudi Vision 2030: Recommendations From a Saudi Experts Meeting

Author

Zaini R, Alrehaily A, Alhazmi A, Halabi H, Mohamed H, and Almoallim H

Subjects
rheumatology, residents, saudi, fellowship, training, training program, Diseases of the musculoskeletal system, RC925-935
Abstract

Rania Zaini,1 Ali Alrehaily,2,3 Ahmed Alhazmi,4,5 Hussein Halabi,6 Heba Mohamed,7 Hani Almoallim8,9 1Department of Medical Education, Faculty of Medicine, Umm Alqura University, Makkah, Saudi Arabia; 2Department of Medicine, Security Forces Hospital Program, Riyadh, Saudi Arabia; 3Chairman of the Scientific Committee of Adult Rheumatology Fellowship Program, Saudi Commission for Health Specialties (SCFHS), Riyadh, Saudi Arabia; 4Department of Medicine, King Fahad Armed Forces Hospital (KFAFH), Jeddah, Saudi Arabia; 5Chairman, Supervisory Committee for Saudi Board Adult Rheumatology Fellowship Program in Western Region, Saudi Commission For Health Specialties (SCFHS), Riyadh, Saudi Arabia; 6Department of Medicine, King Faisal Specialist Hospital And Research Center, Jeddah, Saudi Arabia; 7Pfizer Biopharmaceutical Group, Emerging Markets, Riyadh, Saudi Arabia; 8Department of Medicine, Faculty of Medicine, Umm Alqura University, Makkah, Saudi Arabia; 9Alzaidi Chair of Research in Rheumatic Diseases, Umm Alqura University, Makkah, Saudi ArabiaCorrespondence: Hani Almoallim 6604 Gais Bin Doraih, Alnaeem, Jeddah 23621-3514, Saudi ArabiaEmail hmmoallim@uqu.edu.saBackground: Worldwide research anticipates that a current shortage of rheumatologists will exacerbate over the next decade, whereas the need for arthritis specialists will continue to escalate. Saudi Arabia (SA) also encounters a limited geographical distribution of rheumatologists and rheumatology fellowship training centres.Objective: Reporting the Saudi rheumatologists’ advisory meeting conducted in Makkah, SA in January 2020 with the aim to discuss the “Saudi Vision 2030” for rheumatology training programs.Materials and Methods: A meeting of Saudi rheumatology experts and consultants was conducted to address the future directions, challenges, and recommendations of rheumatology training. The 10th Rheumatology Practice Symposium was organised by Alzaidi Chair of Research in Rheumatic Diseases (ZCRD), and conducted in Makkah Commerce Chamber, Makkah, SA on January 28, 2020. More than 30 consultants and rheumatology fellows with five Saudi experts in the field of rheumatology assembled to form 10 recommendations that tackle rheumatology training challenges in SA.Results: The meeting recommendations shed light on the clinical practice of rheumatology training in SA; challenges and opportunities in rheumatology fellowship programs; efforts of the Saudi Commission for Health Specialties (SCFHS) to design and implement a competent postgraduate rheumatology training; and challenges with trainers, trainee, and within training centres.Conclusion: To address rheumatology challenges in SA, rheumatology consultants and fellows assembled to form 10 recommendations. The recommendations tackled the challenges of rheumatology fellowship programs and the efforts to implement a competent postgraduate rheumatology training. These recommendations are expected to lead us successfully to fulfil our ambition in the “Saudi Vision of 2030”.Keywords: rheumatology, residents, Saudi, fellowship, training, training program

Published
2020

5. POS0273 POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVAD STUDY

Author

Sen, P., primary, Ravichandran, N., additional, Joshi, M., additional, Saha, S., additional, Jagtap, K., additional, Agarwal, V., additional, Distler, O., additional, Nikiphorou, E., additional, Tan, A. L., additional, Katsuyuki Shinjo, S., additional, Ziade, N., additional, Velikova, T., additional, Milchert, M., additional, Parodis, I., additional, Gracia-Ramos, A. E., additional, Cavagna, L., additional, Kuwana, M., additional, Knitza, J., additional, Makol, A., additional, Patel, A., additional, Pauling, J., additional, Wincup, C., additional, Barman, B., additional, Zamora-Tehozol, E. A., additional, Rojas-Serrano, J., additional, Garcia-De La Torre, I., additional, Colunga-Pedraza, I. J., additional, Merayo-Chalico, J., additional, Katchamart, W., additional, Goo, P. A., additional, Chen, Y. M., additional, Hoff, L. S., additional, Kibbi, L., additional, Halabi, H., additional, Vaidya, B., additional, Shaharir, S. S., additional, Shumnalieva, R., additional, Hasan, A. T. M. T., additional, Dzifa, D., additional, Toro Gutierrez, C. E., additional, Vinicio Caballero, C., additional, Lilleker, J. B., additional, Salim, B., additional, Gheita, T. A., additional, Chatterjee, T., additional, Nune, A., additional, Saavedra, M. A., additional, Day, J., additional, Chinoy, H., additional, Aggarwal, R., additional, and Gupta, L., additional

Published
2023
Full Text
View/download PDF

6. POS1542 THE PSORIATIC ARTHRITIS IMPACT OF DISEASE (PSAID-12) QUESTIONNAIRE IS VALID IN ARABIC AND STRONGLY LINKED TO DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN ARAB-SPEAKING COUNTRIES: AN ARLAR INITIATIVE

Author

Ziade, N., primary, Abbas, N., additional, Hmamouchi, I., additional, Kibbi, L., additional, Maroof, A., additional, Zorkany, B., additional, Al-Ani, N. A., additional, Ridha, A., additional, Ihsan, N., additional, Isho Gorial, F., additional, Al Chama, N., additional, Haouichet, C., additional, Alnaimat, F., additional, Hannawi, S., additional, Atawina, S., additional, Halabi, H., additional, Mashaleh, M., additional, Aljazwi, L., additional, Abogamal, A., additional, Ayoub, L., additional, Bouajina, E., additional, Bahiri, R., additional, Saad, S., additional, Sabkar, M., additional, Aouad, K., additional, and Gossec, L., additional

Published
2023
Full Text
View/download PDF

7. AB1148 PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OF PSORIATIC ARTHRITIS APPEAR MORE IN AGREEMENT IN ARAB COUNTRIES THAN PREVIOUSLY REPORTED ELSEWHERE – AN INTERNATIONAL STUDY UNDER THE AEGIS OF ARLAR

Author

Ziade, N., primary, Abbas, N., additional, Kibbi, L., additional, Maroof, A., additional, Zorkany, B., additional, Al-Ani, N. A., additional, Ridha, A., additional, Ihsan, N., additional, Isho Gorial, F., additional, Al Chama, N., additional, Haouichet, C., additional, Alnaimat, F., additional, Hannawi, S., additional, Atawina, S., additional, Halabi, H., additional, Mashaleh, M., additional, Aljazwi, L., additional, Abogamal, A., additional, Ayoub, L., additional, Bouajina, E., additional, Bahiri, R., additional, Saad, S., additional, Sabkar, M., additional, Aouad, K., additional, Gossec, L., additional, and Hmamouchi, I., additional

Published
2023
Full Text
View/download PDF

8. Do Trade Credit and Bank Credit Complement or Substitute Each Other in Public and Private Firms?

Author

Afrifa, G.A, Tingbani, I., Alshehabi, A., Halabi, H., Afrifa, G.A, Tingbani, I., Alshehabi, A., and Halabi, H.

Abstract

In this study, we analyse the complementary and substitution effect between trade credit (TC) and short-term bank credit (BC) for public and private firms in the UK. Using a sample of 254,352 firm-year observations over the period 2008-2021, we find TC and BC are substitutes for public firms that have easy access to cheap external finance. In contrast, TC and BC are complements for private firms that have limited access to alternative financing resources, such as financial markets. Importantly, our results show that public firms are faster in adjusting towards the optimum level of their TC and BC than private firms in an attempt to determine the appropriate mix between these two types of financing. Our study introduces new evidence on the efficient management of TC and BC for public and private firms.

Published
2023

9. Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys

Author

Sen, P, Naveen, R, Houshmand, N, Kia, Sm, Joshi, M, Saha, S, Jagtap, K, Agarwal, V, Nune, A, Nikiphorou, E, Tan, Al, Shinjo, Sk, Ziade, N, Velikova, T, Milchert, M, Parodis, I, Gracia-Ramos, Ae, Cavagna, L, Kuwana, M, Knitza, J, Makol, A, Patel, A, Pauling, Jd, Wincup, C, Barman, B, Tehozol, Eaz, Serrano, Jr, de la Torre, I, Colunga-Pedraza, Ij, Merayo-Chalico, J, Chibuzo, Oc, Katchamart, W, Goo, Pa, Shumnalieva, R, Chen, Ym, Hoff, Ls, El Kibbi, L, Halabi, H, Vaidya, B, Shaharir, Ss, Hasan, Atmt, Dey, D, Gutierrez, Cet, Caballero-Uribe, Cv, Lilleker, Jb, Salim, B, Gheita, T, Chatterjee, T, Distler, O, Saavedra, Ma, Day, J, Chinoy, H, COVAD Study Grp, Kardes, S, Kardes, Sa, Andreoli, L, Lini, D, Screiber, K, Vince, Mn, Singh, Yp, Ranjan, R, Jain, A, Pandya, Sc, Pilania, Rk, Sharma, A, Manoj, Mm, Gupta, V, Kavadichanda, Cg, Patro, Ps, Ajmani, S, Phatak, S, Goswami, Rp, Chowdhury, Ac, Mathew, Aj, Shenoy, P, Asranna, A, Bommakanti, Kt, Shukla, A, Pande, Ar, Chandwar, K, Ghodke, A, Boro, H, Fazal, Zz, Cansu, Du, Yildirim, R, Gasparyan, Ay, Del Papa, N, Sambataro, G, Fabiola, A, Govoni, M, Parisi, S, Bocci, Eb, Sebastiani, Gd, Fusaro, E, Sebastiani, M, Quartuccio, L, Franceschini, F, Sainaghi, Pp, Orsolini, G, De Angelis, R, Danielli, Mg, Venerito, V, Grignaschi, S, Giollo, A, Alluno, A, Ioannone, F, Fornaro, M, Traboco, Ls, Wibowo, Sak, Loarce-Martos, J, Prieto-Gonzalez, S, Gonzalez, Ra, Yoshida, A, Nakashima, R, Sato, S, Kimura, N, Kaneko, Y, Gono, T, Tomaras, S, Proft, Fn, Holzer, Mt, Gromova, Ma, Aharonov, O, Griger, Z, Hmamouchi, I, El Bouchti, I, Baba, Z, Giannini, M, Maurier, F, Campagne, J, Meyer, A, Langguth, D, Limaye, V, Needham, M, Srivastav, N, Hudson, M, Landon-Cardinal, O, Zuleta, Wgr, Arbelaez, A, Cajas, J, Silva, Jap, Fonseca, Je, Zimba, O, Bohdana, D, Ima-Edomwonyi, U, Dedeke, I, Airenakho, E, Madu, Nh, Yerima, A, Olaosebikan, H, Becky, A, Koussougbo, Od, Palalane, E, So, H, Ugarte-Gil, Mf, Chinchay, L, Bernaola, Jp, Pimentel, V, Fathi, Hm, Mohammed, Rha, Harifi, G, Fuentes-Silva, Y, Cabriza, K, Losanto, J, Colaman, N, Cachafeiro-Vilar, A, Bautista, Gg, Ejg, Ho, Gonzalez, R, Nunez, Ls, Vergara, Mc, Baez, Jt, Alonzo, H, Pastelin, Cbs, Salinas, Rg, Obiols, Aq, Chavez, N, Ordonez, Ab, Argueta, S, Llerena, Gar, Sierra-Zorita, R, Arrieta, D, Hidalgo, Er, Saenz, R, Escalante, Mi, Morales, R, Calapaqui, W, Quezada, I, Arredondo, G, Aggarwal, R, and Gupta, L

Subjects
Rheumatology, idiopathic inflammatory myopathies, COVID-19 vaccines, vaccine hesitancy, registries, Pharmacology (medical), autoimmune disease
Abstract

ObjectiveCOVID-19 vaccines have a favorable safety profile in patients with autoimmune rheumatic diseases (AIRDs) such as idiopathic inflammatory myopathies (IIMs); however, hesitancy continues to persist among these patients. Therefore, we studied the prevalence, predictors and reasons for hesitancy in patients with IIMs, other AIRDs, non-rheumatic autoimmune diseases (nrAIDs) and healthy controls (HCs), using data from the two international COVID-19 Vaccination in Autoimmune Diseases (COVAD) e-surveys.MethodsThe first and second COVAD patient self-reported e-surveys were circulated from March to December 2021, and February to June 2022 (ongoing). We collected data on demographics, comorbidities, COVID-19 infection and vaccination history, reasons for hesitancy, and patient reported outcomes. Predictors of hesitancy were analysed using regression models in different groups.ResultsWe analysed data from 18 882 (COVAD-1) and 7666 (COVAD-2) respondents. Reassuringly, hesitancy decreased from 2021 (16.5%) to 2022 (5.1%) (OR: 0.26; 95% CI: 0.24, 0.30, P ConclusionVaccine hesitancy has decreased from 2021 to 2022, long-term safety concerns remain among patients with IIMs, particularly in Caucasians and those with poor physical function.

Published
2023

12. Acceptabilité de la vaccination contre la Covid-19 chez les patients atteints de maladies rhumatismales chroniques et les professionnels de santé

Author

Ziade, N., primary, Metawee, M., additional, Hmamouchi, I., additional, Abdullateef, N., additional, Halabi, H., additional, Eissa, M., additional, Elrakawi, M., additional, Masri, B., additional, Abutiban, F., additional, Hamdi, W., additional, Adnan, A., additional, Abi Najm, A., additional, Felten, R., additional, Arnaud, L., additional, and El Kibbi, L., additional

Published
2021
Full Text
View/download PDF

13. The impact of international diversification on credit scores: Evidence from the UK

Author

Halabi, H., Alshehabi, A., Wood, G., Afrifa, G.A., Halabi, H., Alshehabi, A., Wood, G., and Afrifa, G.A.

Abstract

Despite the great deal of previous research into international diversification, we know little about the impact of international diversification on firms’ credit scores. Drawing upon the resource-based view and transaction cost economics, we examine the relationship between international diversification and credit scores by using a large sample of 6,557 UK firms between 2016 and 2017. We find an inverted U-shaped relationship between international diversification and firms’ credit scores, indicating that the effect of international diversification on credit scores is initially positive but becomes negative with over-diversification. In addition, we find that R&D intensity positively moderates the relationship between international diversification and credit score, implying that the credit scores of highly diversified firms improve as they increase their investment in R&D. Further analysis suggests that a firm’s credit score becomes less dependent on international diversification for large firms, firms in concentrated industries, firms in the manufacturing sector, and firms distant from key metropolitan areas, such as London.

Published
2021

14. AB0104 CONCORDANCE BETWEEN THE PHYSICIAN’S AND THE PATIENT’S ASSESSMENT OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS: RESULTS OF THE AUTODAS-MEAC STUDY AT ONE YEAR

Author

Ziade, N., primary, Al Emadi, S., additional, Abu Jbara, M., additional, Saad, S., additional, Kibbi, L., additional, Merheb, G., additional, Badsha, H., additional, Harifi, G., additional, Alam, E., additional, Ayko, A., additional, Zorkany, B., additional, Daher, A., additional, Halabi, H., additional, Mashaleh, M., additional, Masri, B., additional, Messaykeh, J., additional, Mroue’, K., additional, Salloum, N., additional, and Arayssi, T., additional

Published
2021
Full Text
View/download PDF

15. POS0275-HPR CONCORDANCE BETWEEN THE PHYSICIAN’S AND THE NURSE’S ASSESSMENT OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS USING DAS-28, CDAI AND SDAI IN SEVEN MIDDLE EASTERN ARAB COUNTRIES

Author

Ziade, N., primary, Zorkany, B., additional, Al Emadi, S., additional, Abu Jbara, M., additional, Halabi, H., additional, Saad, S., additional, Kibbi, L., additional, Mashaleh, M., additional, Badsha, H., additional, Harifi, G., additional, Ayko, A., additional, Alam, E., additional, Daher, A., additional, Masri, B., additional, Merheb, G., additional, Messaykeh, J., additional, Mroue’, K., additional, Salloum, N., additional, and Arayssi, T., additional

Published
2021
Full Text
View/download PDF

16. AB0566 CONSENSUS-BASED RECOMMENDATIONS FOR THE MANAGEMENT OF PSORIATIC ARTHRITIS IN THE KINGDOM OF SAUDI ARABIA

Author

Alrayes, H., primary, Alazmi, M., additional, Alderaan, K., additional, Alghamdi, M., additional, Alghanim, N., additional, Alhazmi, A., additional, Alkhadhrawi, N., additional, Almohideb, M., additional, Attar, S., additional, Alzahrani, Z. A., additional, Bedaiwi, M., additional, Zakaria, N., additional, and Halabi, H., additional

Published
2021
Full Text
View/download PDF

27. PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OF PSORIATIC ARTHRITIS APPEAR MORE IN AGREEMENT IN ARAB COUNTRIES THAN PREVIOUSLY REPORTED ELSEWHERE - AN INTERNATIONAL STUDY UNDER THE AEGIS OF ARLAR.

Author

Ziade, N., Abbas, N., Kibbi, L., Maroof, A., Zorkany, B., Al-Ani, N. A., Ridha, A., Ihsan, N., Gorial, F. Isho, Al Chama, N., Haouichet, C., Alnaimat, F., Hannawi, S., Atawina, S., Halabi, H., Mashaleh, M., Aljazwi, L., Abogamal, A., Ayoub, L., and Bouajina, E.

Published
2023
Full Text
View/download PDF

28. THE PSORIATIC ARTHRITIS IMPACT OF DISEASE (PSAID-12) QUESTIONNAIRE IS VALID IN ARABIC AND STRONGLY LINKED TO DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN ARAB-SPEAKING COUNTRIES: AN ARLAR INITIATIVE.

Author

Ziade, N., Abbas, N., Hmamouchi, I., Kibbi, L., Maroof, A., Zorkany, B., Al-Ani, N. A., Ridha, A., Ihsan, N., Gorial, F. Isho, Al Chama, N., Haouichet, C., Alnaimat, F., Hannawi, S., Atawina, S., Halabi, H., Mashaleh, M., Aljazwi, L., Abogamal, A., and Ayoub, L.

Published
2023
Full Text
View/download PDF

35. SAT0103 Variations in the Prescription Patterns of Physicians for Patients with RA across Several Arab States

Author

Gad El Haq, W., primary, Mahfoud, Z., additional, Aranki, G., additional, Hani, F., additional, Mandey, S.M., additional, Mook Kanamori, M., additional, AlEmadi, S., additional, Hammoudeh, M., additional, Masri, B., additional, Badsha, H., additional, Halabi, H., additional, Uthman, I., additional, Kazkaz, L., additional, Sahyboub, R., additional, Saxena, R., additional, Plenge, R., additional, and Arayssi, T., additional

Published
2014
Full Text
View/download PDF

36. AB0139 Genome-Wide Analysis of Population Structure in A Multi-National Arab Rheumatoid Arthritis Case-Control Study

Author

Saxena, R., primary, Bjonnes, A., additional, Mahfoud, Z., additional, Gad El Haq, W., additional, Mandey, S., additional, Mook Kanamori, M., additional, Aranki, G., additional, AlEmadi, S., additional, Hammoudeh, M., additional, Masri, B., additional, Badsha, H., additional, Halabi, H., additional, Uthman, I., additional, Kazkaz, L., additional, Sahyboub, R., additional, Plenge, R., additional, and Arayssi, T., additional

Published
2014
Full Text
View/download PDF

44. Pediatrics Laboratory Research

Author

Karakoula, K., primary, Bigner, D. D., additional, Keir, S., additional, Thomas, D. G., additional, Darling, J., additional, Warr, T., additional, Al-Halabi, H., additional, Albrecht, S., additional, Guiot, M. C., additional, Kelkner, A., additional, Sahebjam, S., additional, Kavan, P., additional, Freeman, C. R., additional, Muanza, T., additional, Jabado, N., additional, Bielen, A., additional, Perryman, L., additional, Box, G., additional, Popov, S., additional, Jeay, S., additional, Hofmann, F., additional, Hargrave, D., additional, Eccles, S., additional, Jones, C., additional, Dubuc, A. M., additional, Mack, S., additional, Nakahara, Y., additional, Garzia, L., additional, Northcott, P. A., additional, Kongkham, P., additional, Baylin, S., additional, Watkins, N., additional, Taylor, M. D., additional, Paugh, B. S., additional, Qu, C., additional, Zhang, J., additional, Geyer, J. R., additional, Chi, S., additional, da Silva, N. S., additional, Baker, J., additional, Gajjar, A., additional, Ellison, D. W., additional, Broniscer, A., additional, Baker, S. J., additional, Mainwaring, L. A., additional, Taylor, M., additional, Dupuy, A., additional, Kenney, A. M., additional, Williams, S. C., additional, Zagzag, D., additional, Chiriboga, L., additional, Becher, O. C., additional, von Deimling, A., additional, Allen, J. C., additional, Karajannis, M. A., additional, Stearns, D., additional, von Buren, A. O., additional, Donson, A., additional, Foreman, N., additional, Eberhart, C., additional, Taylor, P., additional, Kang, N., additional, Das, C. M., additional, Rajaram, V., additional, Aguilera, D. G., additional, Goldman, S., additional, Fangusaro, J., additional, Gopalakrishnan, V., additional, Su, X., additional, Kommagani, R., additional, Wolff, J. E., additional, Kadakia, M. P., additional, and Flores, E. R., additional

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results